Announcements Trials

Browse Landscape

Sponsor

Conditions

Breast Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Vaginal Atrophy 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Sexual Dysfunction, Physiological 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Depression 1 Carcinoma, Ovarian Epithelial 1 Anxiety Disorders 1

Interventions

Oxaliplatin 49 Fluorouracil 45 Leucovorin 42 Capecitabine 40 Irinotecan 31 Bevacizumab 31 Radiotherapy 24 Cetuximab 23 Radiation 13 Panitumumab 13 Folfox protocol 10 Surgical Procedures, Operative 9 IFL protocol 8 Radiotherapy, Intensity-Modulated 6 Magnetic Resonance Spectroscopy 6 aflibercept 5 Immunohistochemistry 5 Gene Expression Profiling 5 Chemotherapy, Adjuvant 5 Fluorodeoxyglucose F18 4 Floxuridine 4 Celecoxib 4 trifluridine tipiracil drug combination 3 dehydroftorafur 3 XELOX 3 Sorafenib 3 Ramucirumab 3 Neoadjuvant Therapy 3 Erlotinib Hydrochloride 3 Drug Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Rectal Neoplasms × Dehydroepiandrosterone × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡